Boston Scientific Corporation
BSX
$73.85
-$2.37-3.11%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.36% | 0.08% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.36% | 0.08% | |||
| Cost of Revenue | 5.15% | -7.03% | |||
| Gross Profit | 4.02% | 3.52% | |||
| SG&A Expenses | 5.34% | 1.46% | |||
| Depreciation & Amortization | 1.33% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.73% | -2.50% | |||
| Operating Income | -0.86% | 11.35% | |||
| Income Before Tax | -25.37% | -0.32% | |||
| Income Tax Expenses | -83.61% | 25.34% | |||
| Earnings from Continuing Operations | -11.26% | -5.03% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -10.99% | -5.27% | |||
| EBIT | -0.86% | 11.35% | |||
| EBITDA | 1.01% | 8.84% | |||
| EPS Basic | -11.05% | -5.39% | |||
| Normalized Basic EPS | 8.06% | -27.95% | |||
| EPS Diluted | -11.66% | -3.87% | |||
| Normalized Diluted EPS | 8.11% | -27.95% | |||
| Average Basic Shares Outstanding | 0.07% | 0.12% | |||
| Average Diluted Shares Outstanding | 0.02% | 0.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||